05/14/2013 - 2:14pm

Americans and their health care plans are spending less on medicines and health services. Is that a good thing?

05/14/2013 - 11:03am

Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.

05/14/2013 - 8:58am

A study conducted by researchers at CVS Caremark and Brigham and Women's Hospital and published in the May issue of the American Heart Journal found that non-white patients had 50% greater odds of statin medication nonadherence compared with white patients, while women had 10% greater odds of statin nonadherence compared with men.

05/14/2013 - 8:42am

A Harris Interactive poll released found that 44% of all adults reported getting their flu shot this past season, the second time flu shot penetration has reached that high in four years, and even more are expected to get a flu shot next season.

05/13/2013 - 3:31pm

New Jersey Gov. Chris Christie signed legislation into law that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

05/13/2013 - 2:49pm

The Generic Pharmaceutical Association has promoted Jason Money to associate VP federal government affairs, the trade group said Monday.

05/13/2013 - 1:35pm

A ruling by the Food and Drug Administration means that generic versions of an opioid painkiller made by Endo Pharmaceuticals can stay on the market, drawing criticism from the drug maker.

05/10/2013 - 3:54pm

Actavis is looking into the possibility of buying Warner Chilcott, the generic drug maker said.

05/09/2013 - 5:45pm

The November 2011 expiration of Pfizer's patent on the cholesterol drug Lipitor and Ranbaxy Labs' release of the generic version received significant play in the media, particularly due to the theretofore status of Lipitor (atorvastatin calcium) as the drug with the highest sales in the country, $7.7 billion in the United States, according to healthcare analytics firm IMS Health.